Furthermore, SRC contributes to the emergence of malignant phenotypes in renal cancer cells, particularly due to the resistance of BCL-XL to apoptosis and angiogenesis stimulated by SRC-STAT3-VEGF signaling (Chatterjee et al., 2022). This evidence concerns the gene SRC and renal carcinoma.